We used 44 splenectomized dogs to study the effects of isovolemic hemodilution with a crystalloid solution. The dogs were randomly divided into a hemodilution and a control group. In each group, 17 dogs were subjected to 6 hours of internal carotid and middle cerebral artery occlusion, and five dogs received sham operations. Isovolemic hemodilution by phlebotomy and Ringer's lactate infusion was performed 30 minutes after arterial occlusion and resulted in an average hematocrit of 32-33%. Hemodilution significantly reduced viscosity, fibrinogen and total protein concentrations, and plasma oncotic pressure. Systemic arterial blood pressure and pulmonary wedge pressure decreased slightly with hemodilution, but central venous pressure and pulmonary arterial pressure did not change significantly. There was a similar decrease in cardiac index in both hemodiluted and control dogs, which may have been due to the effects of barbiturate anesthesia. Intracranial pressure increased significantly with time in all dogs subjected to arterial occlusion, but this increase was significantly more severe in the hemodiluted dogs. Specific gravity, measured just after the dogs were killed, 6 hours after hemodilution, was significantly lower in the white matter and basal ganglia of the left (ischemic) hemisphere in hemodiluted dogs than in controls. Regional cerebral blood flow decreased significantly in the left hemisphere after arterial occlusion.This decrease was almost completely reversed by hemodilution except in the basal ganglia, where the increase in edema caused by hemodilution was the greatest. (Stroke 1989;20:534-540)
H emodilution has received much recent attention as a potential palliative therapy for stroke. Although some clinical studies have suggested a beneficial effect, 1 -4 larger randomized studies have failed to prove a significant benefit.
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The negative results of these trials may be related to the heterogeneity of the patients entered and to the failure to perform hemodilution early enough and to a sufficient degree. 7 These problems can be overcome experimentally and, in fact, substantial benefit has been demonstrated in a dog model of focal cerebral ischemia with hypervolemic hemodilution by Wood and coworkers 89 and with isovolemic hemodilution by our group. 1011 In both the clinical and experimental studies, colloids were used as the hemodiluting agent. Colloids have the disadvantage of being expensive and, depending on the type, can result in disease transmission (human plasma) or in anaphylactic reactions and coagulation disorders (dextrans and starches). A large body of literature suggests that crystalloids, particularly the balanced salt solutions, are as effective as colloids in restoring normal circulatory dynamics after severe losses of blood and fluids such as occur with trauma and burns in the clinical setting and with hemorrhagic shock in the experimental setting. 12 -' 4 No study, however, has concerned patients or animals with primary brain injury. In the setting of traumatic or ischemic brain injury where the blood-brain barrier may be disrupted, it is not known whether one form of fluid therapy is preferable to the other. Colloids have been used in all the studies of hemodilution and brain ischemia under the assumption that crystalloids would result in increased brain edema and intracranial hypertension; this assumption remains unproven. Therefore, we studied isovolemic hemodilution by blood removal and replacement with Ring-
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er's lactate (RL) in dogs with focal cerebral ischemia. We report the acute effects of such therapy on hemodynamic and rheologic parameters, brain specific gravity (SG), plasma protein concentration and oncotic pressure, intracranial pressure (ICP), and regional cerebral blood flow (rCBF). We compare our results with those obtained with an identical protocol but using low-molecular-weight dextran (LMD) instead of RL as the hemodiluting agent. Our ongoing study of the chronic effects of this therapy on survival, neurologic condition, and size of brain infarct will be reported later.
Materials and Methods
We used 44 conditioned mongrel dogs of either sex weighing 10-20 kg. National Institutes of Health standards were met or exceeded in the preparation, surgical and anesthetic techniques, and housing of the dogs. We randomly divided these dogs into two groups, a hemodilution group and a nonhemodilution (control) group. In each group, a subgroup of 17 dogs was subjected to 6 hours of occlusion of the internal carotid artery (ICA) and the middle cerebral artery (MCA), and a subgroup of five dogs received sham operation.
l0 " We took baseline measurements of 1) total blood volume (TBV); 2) the rheologic parameters blood viscosity, hematocrit (Hct), and plasma fibrinogen level; 3) the hemodynamic parameters mean systemic arterial pressure (MSAP), central venous pressure, mean pulmonary arterial pressure, pulmonary wedge pressure (PWP), cardiac output (CO), and cardiac index (CI); 4) total protein concentration and oncotic and osmotic pressures of the blood; and 5) intracranial pressure (ICP) in all dogs immediately before craniectomy.
Isovolemic hemodilution was performed 30 minutes after arterial occlusion or sham operation in the hemodilution group. Hct was measured again at the end of hemodilution to verify that the Hct had reached the designed level. The parameters were measured again 3 hours after arterial occlusion or sham operation (approximately 2 hours after completion of hemodilution in the hemodiluted dogs). The highest value of ICP between arterial occlusion and the second measurement (3 hours after arterial occlusion) was selected as the peak value of ICP. Hct was measured a third time approximately 5 hours after completion of hemodilution in the hemodiluted dogs. After 6 hours of temporary arterial occlusion, reperfusion was achieved by removing the temporary clips. In sham-operated dogs, we performed the same manipulations except for clipping and unclipping.
At four periods during this study, we measured rCBF by radiolabeled microsphere injections. The first measurement was performed before arterial occlusion and the second measurement 30 minutes after it. The third was performed 3 hours after arterial occlusion and the fourth 30 minutes after reperfusion (clip removal).
After the last rCBF measurement, the dogs were killed with potassium chloride, and the brains were quickly removed. Immediately, each brain was sliced coronally at the level of the optic chiasm and at 1 cm anterior and posterior to the optic chiasm. After SG measurements, the rest of the brain was fixed in 10% formaldehyde solution in preparation for measurement of radioactivity for rCBF calculations.
Isovolemic hemodilution was carried out by repeated withdrawals of 50 ml blood and infusion of 150 ml RL. We chose this ratio because in our pilot experiments it maintained isovolemia. Blood volume was determined by a technetium-99m (Tc-99m)-labeled red blood cell in-vivo method. 15 Blood viscosity was determined by a disposable porous-bed viscometer developed by E.W. Merrill and extensively tested in our laboratory. 10 Plasma fibrinogen level was determined by the biceret method. 16 Oncotic pressure was determined by Weil oncometer. 17 rCBF was determined from multiple regions of both hemispheres with radiolabeled microspheres in a manner we have described previously." SG was measured by bromobenzene-kerosene columns as described by others.
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Rheologic and hemodynamic parameters, ICP, and rCBF measurements before and after hemodilution or at the same time in controls were compared by Student's two-tailed paired t test. The gradients of these measurements were then compared by Student's two-tailed unpaired / test. All the values are expressed as mean±SEM. A significant difference was defined as p<0.05.
Results
The changes in TBV, rheologic and hemodynamic parameters, total protein concentrations, and oncotic and osmotic pressures of the blood before and after hemodilution in ischemic and shamoperated dogs were analyzed together. These changes were compared with those of the control dogs in the same 3-hour interval (Table 1) . CI decreased substantially in both groups with time, but there was no significant difference in the decrease between groups. As expected, total protein content and oncotic pressure decreased significantly with hemodilution.
ICP data is summarized in Table 2 . ICP increased significantly with time in both subgroups subjected to arterial occlusion and in the hemodiluted shamoperated subgroup but not in the control shamoperated subgroup. The ICP increase was much greater in the hemodiluted group, particularly when peak ICP was considered (Figure 1) . Figure 2 depicts pertinent rCBF data in dogs subjected to arterial occlusion. Three sites in the MCA territory (gray matter, white matter, and basal ganglia) and two measurement times (30 minutes after occlusion but before hemodilution and 3 hours after arterial occlusion or approximately 2 hours after completion of hemodilution) were selected for presentation. In the hemodiluted dogs, rCBF increased in all areas except the basal ganglia. However, this increase was significant only in the left cortical gray matter. In the control dogs, rCBF tended to decrease at all sites, and this decrease was more prominent in the left (ischemic) hemisphere. Figure 3 compares SGs of the hemodiluted and control groups in each site. SG of the hemodiluted group tended to be lower than that of the control group, especially in the white matter and basal ganglia of the left (ischemic) hemisphere.
Discussion
Our recently completed studies using LMD in a protocol of isovolemic hemodilution (by phlebotomy and replacement with LMD) showed that this therapy markedly reduces the extent of brain infarction resulting from temporary occlusion of the ICA and MCA." This protection is achieved without a concomitant increase in CO or ICP. 10 We followed an identical protocol in our present study except that we achieved hemodilution with RL instead of LMD. We chose RL as the hemodiluting agent because it has been suggested that RL is the best crystalloid for the treatment of shock, for which large infusions are required over a relatively short time. 20 We lowered Hct to approximately 30-32%, as in our previous studies with colloid, because that appears to be the optimal range for tissue oxygen delivery.
2122
Our results show what appears to be a significant increase in TBV in the control dogs. However, as discussed previously, 10 this apparent increase is probably artifactual and related to the fact that our formula for calculating TBV does not allow for the radioactive decay of Tc-99m, a radioisotope of relatively short biologic half-life. As in our study with LMD, MSAP and PWP decreased slightly, though significantly, in the hemodiluted group. The reason for this decrease is not clear, but it may be related to reduction of systemic vascular resistance brought about by the reduced viscosity with hemodilution.
A disturbing aspect of our study is the significant decrease in CI observed with time in both groups. We had noted a similar decrease in our previous study. 10 We suspect that this deterioration in cardiac performance is related to barbiturate anesthesia. 23 For this and many other reasons (including their brain protective effect and their tendency to lower cerebral blood flow [CBF]) barbiturates may not have been the ideal anesthetic for our study. However, we used barbiturates in our previous studies, and in spite of a decrease in CO, we observed an increase in CBF with LMD hemodilution and a marked reduction in infarct size in the hemodiluted compared with the control group.'' We wanted to use an identical protocol in this study to allow for comparisons and, by using a concurrent control group with an equal number of dogs, we felt that we could adequately control for the effect of barbiturates.
As expected, total protein concentration and plasma oncotic pressure were reduced significantly by hemodilution. These decreases are among the most important observed differences when crystalloids instead of colloids are used for volume restoration. 13 -24 Perhaps our most important result is the significant increase in ICP observed as a result of hemodilution with RL. In our study of hemodilution with the colloid LMD, we observed a modest ICP increase in all groups subjected to arterial occlusion but not in the sham-operated group. Since it was actually higher in the control than in the hemodiluted groups, we attributed the ICP increase to ischemia. We concluded that hemodilution with LMD per se did not increase ICP. 10 In contrast, in this study the ICP increase in the dogs hemodiluted with RL was significantly higher than that observed in the control dogs. This difference was particularly pronounced for peak ICP. In addition, a significant ICP increase was noted in the hemodiluted shamoperated dogs but not in the control sham-operated dogs. Other studies have confirmed a similar increase in ICP with crystalloids but not with colloids. 25 -28 It has been postulated that the increase in ICP is due to transcapillary fluid shifts brought about by the reduction in blood oncotic pressure caused by fluid replacement with protein-free electrolyte solutions. 2629 These shifts increase interstitial fluid, total brain volume, and ICP.
Our SG results add support to the above considerations. Indeed, we observed a reduction in SG in the hemodiluted compared with the control dogs with arterial occlusion. This difference in SG was more prominent in the left (ischemic) hemisphere, particularly in the basal ganglia and deep white matter of the MCA territory which is, from our previous results, the area where infarction is most likely to be severe in this model." This suggests that edema formation, to be expected in the area of maximal ischemia, was exacerbated by hemodilution with RL. Again, this contrasts with the results observed with hemodilution with LMD, which resulted in a very significant reduction in infarction and brain edema observed grossly and histopathologically when treated dogs were compared with controls."
Our rCBF results also contrast with those of our previous study of hemodilution with colloid." Whereas hemodilution with colloid increased rCBF most markedly in the basal ganglia, hemodilution with RL significantly increased rCBF only in the cortical gray matter of the ischemic hemisphere. In the basal ganglia we actually observed a slight decrease in rCBF after hemodilution, although this decrease was not as large as that observed in the same period in the control dogs. The explanation for this difference may be found in the results of SG measurements. As stated, the greatest decrease in SG was observed in the basal ganglia of the ischemic hemisphere and only minimal changes were observed in the cortical gray matter. Therefore, it is likely that the beneficial effect on rCBF expected from the rheologic changes attending hemodilution were nullified in the basal ganglia by the exacerbation of edema there. In other regions outside the central core of ischemia, where edema formation (as indirectly reflected by SG) was less severe, we observed the expected improvement in rCBF with hemodilution. In fact, this rCBF increase was most striking in the sham-operated dogs. A similar increase in CBF in normal rabbits after isovolemic hemodilution with RL was reported by Todd et al.
the observed increase in CO after volume expansion. 3031 With isovolemic hemodilution, however, we actually observed a decrease in CO in this as well as in our previous study. 10 Therefore, the rCBF increase in most regions of the brain observed after hemodilution in this model is most likely attributable to the decreased viscosity observed after hemodilution with both colloids (LMD) and crystalloids (RL). Others have also believed that the most important factor in the observed increases in CBF after hemodilution is the decrease in viscosity. 9 -32 - 33 As discussed in our previous reports, this effect is maximal at the level of the microcirculation, where shear rate is low, and it is likely that under ischemic conditions, with further decreases in shear rate, the effect would be even greater. 10 "
Our study has not addressed the most important question: Is isovolemic hemodilution with RL as effective in improving survival and neurologic condition and in decreasing infarct size in this model as hemodilution with LMD was proven to be? 11 This question can be properly addressed only in a chronic study with concurrent groups hemodiluted with LMD or RL as well as a nonhemodiluted control group. Such a study is currently under way in our laboratory.
In summary, isovolemic hemodilution achieved by phlebotomy and volume replacement with a balanced salt solution resulted in changes in rheologic and hemodynamic parameters comparable with those observed in a previous study with hemodilution by phlebotomy and replacement with a colloid. Such hemodilution with a crystalloid, however, significantly decreased SG, likely secondary to brain edema, in ischemic brain. Likewise, ICP increased significantly after hemodilution with crystalloid, which is in contrast with our observations after hemodilution with colloid. CBF generally increased with hemodilution with crystalloid except in the core area of ischemia, where (probably secondary to increased edema formation) it decreased slightly. The question of effectiveness of hemodilution with crystalloid remains to be answered.
